Hendi Pharmaceuticals: Shareholder Lei Xiaoyan has reduced her holdings by 0.998%

Hendi Pharmaceutical Announcement: Shareholder Lei Xiaoyan will reduce 4,167,100 shares through centralized bidding from November 18, 2025, to February 17, 2026. The average reduction price is 14.25 yuan per share, accounting for 0.998% of the company’s total share capital. After the reduction, the shareholding will decrease to 11,492,900 shares, representing 2.752%, down from 15,660,000 shares, or 3.75%. The shares being reduced are all from shares issued before the company’s initial public offering. The reduction plan has expired and complies with relevant regulations.